Why the study?
Studies assessing the biological variability of cardiac troponin have yielded varying significant change values, prompting a revisit in light of the recent redefinition of myocardial infarction.
Key points are not available for this paper at this time.
Design
Mini-review
Answers are grounded in this paper and cite their sources.
Study variability in troponin biological changes warrants cautious serial interpretation; leaves open standardized significant-change thresholds.
percentile. These hs-cTn assays are also able to detect the normal variations in cTn results that are due to biological variability. Understanding and quantifying the normal variations in cTn is important as this would allow significant changes to be better defined. Numerous studies have sought to investigate the biological variability of cTn over the last ten years. Such studies are usually conducted in healthy individuals, however individuals with chronic cardiac disease or chronic renal failure have also been examined. These studies have yielded varying results in regards to significant change values for cTn. In light of the recent redefinition for myocardial infarction, the purpose of this mini-review is to revisit the biological variability of cTn. In particular, we outline concepts for determining a significant change value, review the results of previous studies on the biological variation of cTn and discuss potential considerations for clinical practice.
No takes yet. Share an insight, caveat, or question.
Lan et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: